Six weeks of visual perturbation training reduced visual dependency and improved temporal gait characteristics to a greater extent than treadmill training alone in people with early-stage Parkinson’s ...
Oral infigratinib achieved the highest growth velocity reported to date in a randomized achondroplasia trial, growing 2.10 cm ...
An expert panel identified the shingles vaccine and sildenafil as the top candidates for repurposing to protect against Alzheimer's disease. 2. Leveraging existing drugs with established safety data ...
Computed tomography angiography of the head and neck (CTAHN) is most likely to reveal an acute finding that changes emergency management in patients presenting with suspected stroke, especially when ...
Use of glucagon-like peptide-1 (GLP-1) receptor agonists was associated with reduced risk of developing substance use disorders among US veterans with type 2 diabetes. Evidence Rating Level: 2 (Good) ...
In this cohort study, the quadrivalent human papillomavirus (HPV) vaccine provides strong, long-lasting protection against ...
In this cohort of very preterm infants, maternal exposure to low levels of greenness, high levels of ozone, and low ...
Oral remibrutinib successfully met its primary endpoint in the Phase III RemIND trial, delivering significant symptom relief for chronic inducible urticaria. 2. As a selective BTK inhibitor, this ...
The FDA has granted priority review for iberdomide, a first-in-class oral CELMoD designed to degrade transcription factors more effectively than earlier agents. 2. Priority review was supported by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results